Mistletoe for Dogs with Cancer

Mistletoe is a natural therapy that may support and improve your dog’s quality of life while fighting canine cancer.

What Is Mistletoe?

Mistletoe is a semi-parasitic shrub that grows on a variety of host trees1. It has been used by humans for hundreds of years and was even touted as the “all healer” by Celtic druids2. It wasn’t until Rudolf Steiner introduced mistletoe for clinical treatment in the 1920s that it was applied to humans on the basis that it could be used as a therapeutic agent to correct the imbalances causing cancer1.

There are several subspecies of mistletoe, but the two most commonly used for medicinal application are the European, or white-berry, mistletoe (Viscus album abietis) and the Asian mistletoe (Viscum album coloratum)2. The latter is less formally studied, but has been found to have similar properties to that of the European subspecies3.

Its large variety of biologically active ingredients is what makes mistletoe so powerful2.

  • Lectins – Proteins that bind to carbohydrates. Lectins are known to boost the immune system and possess anti-tumor properties.
  • Viscotoxins – Small proteins that are able to kill cells and stimulate the immune system.
  • Flavonoids – A natural secondary metabolite known to regulate cellular activity and protect against toxins and everyday stressors faced by cells.
  • Thiols – A compound that has a suite of antioxidant properties that help protect cells from oxidative damage.
  • Triterpenes – A large class of natural products that carry out a range of biological activities and are known to be anti-inflammatory.

Evidence for Efficacy

Research on mistletoe provides several lines of evidence related to its effect on cells and efficacy for its cancer fighting properties. In a meta-analysis review of over 1,200 citations in the PubMed database, studies demonstrated immunomodulatory, cytotoxic and proapoptotic, anti-angiogenesis, and DNA stabilizing properties associated with mistletoe3.

Mistletoe acts on several different areas of the cell, ultimately stimulating the immune system via an immunomodulating regulating effect2. One mechanism that achieves mistletoe’s anti-inflammatory properties is believed to be its selective inhibition of the COX-2 gene. This gene is responsible for making the COX-2 protein, which is implicated in resisting cell death, increasing cell proliferation, heightening inflammation, and encouraging the creation of new blood vessels that feed tumor growth.4

Of the lectins found in mistletoe, ML-1 is the most predominant. This lectin molecule is comprised of two sub-units.5 While one sub-unit binds to the receptors on the surface of target cells, the other sub-unit inactivates 60S ribosomes. Ribosomes are essentially protein making factories and the cell ultimately dies without them. ML-1 is also known to stimulate cells that actively attack and kill tumor cells. Lectins are considered to have so much potential in the treatment of cancer that laboratories are working to create and test recombinants of them in an effort to design hard-hitting molecules that destroy cancer3.

Research in Dogs

One study investigated the efficacy of mistletoe extract on tumor cells harvested from canine malignant gliomas in the laboratory.5 The extract was added to mebendazole (MBZ), a medication commonly used to treat parasites in domestic animals. This combination appeared to amplify the destruction of cancerous cells. While cells treated with MBZ had an approximately 50% decrease in cell viability, cells treated with MBZ and a high dose of mistletoe extract had 39.3% greater cell death than that observed in the cells only treated with MBZ.

Another study covered the case of a 10-year-old mixed breed male dog who came in with a black skin wound and was diagnosed with melanocytic melanoma6. The dog was prescribed a mistletoe formula that was given subcutaneously near the tumor site once a week for four weeks and then followed up with a modified administration plan. A significant reduction in the size of the wound was noted in as little as four weeks.

European vs. Asian Mistletoe

Note that while the Asian subspecies has been studied and shows similar effects, it has not been studied to the extent of European mistletoe and its efficacy is not as well established. In a meta-analysis examining research studies on mistletoe, 32 used the European subspecies while only 5 used the subspecies native to Asia3.

Common Uses

One of the most promising aspects of mistletoe is that different formulations of varying extracts can be prescribed to treat different types of cancer1. While mistletoe appears to work best with solid tumor cancers, such as lymphoma, mast cell tumors, and sarcomas, its wide-ranging properties will likely benefit numerous cancers.

Any cancers that have low survival rates require novel therapies, such as the administration of nutraceuticals5. For example, malignant gliomas typically have a poor prognosis because chemotherapy treatments are thwarted by the presence of the blood-brain barrier, hypoxic (low oxygen) environments, and the existence of resistant stem-like cell subpopulations5. When conventional treatments such as chemotherapy, surgery, and radiation fail or are prohibitively expensive to you as their owner, mistletoe may be a valuable addition to your dog’s course of cancer fighting therapies7.

If chemotherapy is an option for treating your dog’s cancer, mistletoe may be prescribed as a way to increase your dog’s quality of life8. For example, mistletoe’s immune boosting properties can aid in counteracting the immunodeficiencies caused by chemotherapy7.

Safety and Side Effects

Since the start of mistletoe’s clinical use in the 1920s, no negative side effects have been reported in humans1. However, you may observe some minor side effects in your dog. For example, a local reaction may occur around the injection site and your dog may become lethargic, lose their appetite, and register a mild fever1. This fever is actually perceived as a positive sign, because it indicates that the mistletoe is stimulating your dog’s immune system to rally and destroy cancer cells7.

Mistletoe was well-tolerated in a study of 23 dogs with mammary tumors who were treated with the supplement post-surgery9, and only two out of 18 dogs experienced adverse effects when given mistletoe as a therapeutic agent to treat cancer8.

Can Be Given With

It is advised to first check with your veterinarian and ensure that mistletoe extract will not interfere with any of the current therapies being used to treat your dog’s cancer.

Mistletoe extract is commonly prescribed in combination with conventional therapies such as surgery, chemotherapy, and radiation therapy1. In the case of surgery, it can be used as a post-operation adjuvant therapy. In a study of 56 dogs who had surgery to treat mammary adenocarcinoma, the 23 dogs who were given mistletoe were found to have a lower risk of death than the 33 dogs who were not9.

With chemotherapy, mistletoe reduced the duration and amount of chemotherapy used, and helped support the continued use of conventional drugs to fight cancer instead of stopping treatment due to their side effects1,8.

In addition to conventional therapies, mistletoe can be given with other alternative methods such as herbal medicine or acupuncture1. It may also work well with chemicals known to disrupt the cell cycle due to its synergistic effects. For example, one study found that mistletoe given in conjunction with a medication used to prevent the division of cells in parasites can work synergistically to induce more cell death than either used alone6.

When to Not Use

Commercially manufactured mistletoe extracts should not be given to:

  • Pregnant dogs10
  • Older or weaker dogs (may not fare well with mistletoe use because the initial dosing schedule will result in a fever, which they may not tolerate as well as their younger and healthier counterparts7)

How to Give

Mistletoe extract is usually given as an injection by your veterinarian, but if you are interested you might be able to learn how to give it at home safely.

There are many useful biological agents in mistletoe, so parts of the whole plant are typically found in formulated extracts2. Interestingly, the chemical composition of mistletoe varies based on the species of host tree and the time of year that it is harvested. Commercially available preparations typically take advantage of this by mixing fresh leafy shoots harvested in summer and winter with fruits harvested in winter when the concentrations of lectins and viscotoxins are highest11.

Mistletoe extract is most commonly administered via injection. Typically (but not always), the first round of injections will be done daily, preferably in the morning7. A veterinarian quoted this as costing about $500 or more in 2015. Your veterinarian may do the first injections, and then instruct you on how to administer them at home1. These shots will result in a fever that your dog will have for approximately 5 to 10 days, but shots may be given only weekly or monthly once your dog’s fever breaks1. It could take 2 to 3 weeks to determine the best dose and dose schedule for your dog, so some patience may be needed7.

Subcutaneous (under the skin) injection sites can include the abdominal wall, chest wall, inner thigh, in close proximity to the tumor, or at specific acupuncture points using small gauge needles1. It’s recommended that these sites are rotated to avoid irritation1. Mistletoe extract used for maintenance therapy will depend on the type and severity of your dog’s cancer and may be done temporarily or for the remainder of your dog’s life1. Depending on your dog’s health requirements, oral drops of mistletoe extract, as opposed to injections, may suffice for maintenance care10.

One example of a commercial brand of mistletoe extract is called Iscador®. The product is made for humans, but can also be used for dogs10. Iscador® is made by Iscador AG through a process that starts with harvesting mistletoe branches from four to five different host tree species, ranging in age from 12 to 15 years, in winter and summer12,13. The branches are organized, prepared, and fed into a roller to be mechanically macerated. The aqueous extract is added to the mistletoe’s own lactic acid bacteria and fermented in a 1:1 ratio of branches collected in summer and branches collected in winter. The company offers preparations in different varieties with constant concentrations or in a series of concentrations within one package12.

What If I Miss a Dose?

You may be able to administer the injection and then continue the next dose as normal depending on how long after you realize a dose is missed. However, if a substantial amount of time has passed, it is advised that you simply skip the dose and go about the dosing schedule as usual.

Storage and Handling

Most mistletoe preparations are stored in the refrigerator. If possible, keeping the preparation in a separate compartment of your fridge, such as a vegetable drawer, is best. Before use, you should gently warm the container in your hand14.

Some extract preparations can be stored at room temperature and should be kept in a safe place that is cool and dry14. In either case, heat should be avoided for all types of mistletoe extract preparations14.

Our Take

Mistletoe seems to hold a lot of promise on the cancer fighting front. Research shows that it can act on malignant tumors and increase the efficacy and outcomes of conventional treatments like chemotherapy or surgery. Its wide-ranging applications both in battling cancer and in increasing quality of life make it a potential home-run addition to your dog’s treatment plan. While predictable and generally low risk, the side effects associated with the first round of dosing may not fare well for older or weaker dogs. In addition, owners should consider how comfortable they are giving their dogs injections, particularly with the potentially lifelong commitment of maintenance injections.

  1. Integrative Veterinary Center. Veterinary Use of Mistletoe Extract (Mistletoe R, HelixorR) to Treat Cancer. Publication date unavailable. Updated July 2018. Accessed on November 16, 2022. http://integrativeveterinarycenter.com/wp-content/uploads/2018/07/IVC_IscadorVeterinahttps://functionalnut.sharepoint.com/:w:/s/DCDogCancer.comContent/Ee-s8HMdUuZPsSYObLvTO40BL-z4KQy5oGqAApF9wDUu4g?e=Y0I4zbry-Use.pdf.
  2. Biegel U, Christen O. Mistletoe therapy – support in cancer treatment of animals. FiBL Visum-Vet Group. Publication date unavailable. Updated 2019. Accessed November 16, 2022. https://www.viscumvet.org/fileadmin/viscumvet-documents/en/Flyer_Misteltherapie_2019_EN.pdf.
  3. Bonamin LV, Cunha de Carvalho A, Waisse S. Viscum album (L.) in experimental animal tumors: A meta-analysis. Exp Ther Med. 2017;13:2723-2740.
  4. Kuttan G, Vasudevan DM, Kuttan R. Effect of a preparation from Viscum album on tumor development in vitro and in mice. J Ethnopharmacol 1990;29:35‑41.
  5. Wright A, Watanabe R, Koehler JW. European mistletoe (Viscum album) extract is cytotoxic to canine high-grade astrocytoma cells in vitro and has additive effects with mebendazole. Anim. 2022;9:31.
  6. Valle AC, Andrade R, Sibata M, Carvalho A. Undiluted Viscum album in the treatment of melanoma in a dog (Canis familiaris) – case report. Homeopathy 2020;109:A1-A28.
  7. Middle C. Article 7B – Holistic treatment of cancer – injectable mistletoe (Viscum album). https://www.claremiddle.com/article-7b. No publication data available. Last updated 2015. Accessed November 18, 2022.
  8. Biegel U, Mevissen M, Schuller S, Ruess K, Christen O, Ayrle H, Koch C, Walkenhorst M. Viscum album L., a therapeutic option for neoplastic diseases in companion animals? A systematic review. Complement Med Res. 2022;DOI:10.1159/000525035.
  9. Biegel U, Stratmann, N, Knauf Y, Ruess K, Reif M, Wehrend A. Postsurgical adjuvant treatment with mistletoe extract (Viscum album spp. Album) in canine mammary tumors. Complement Med Res. 2017;24:349-357.
  10. The Holistic Veternary Medicine Centre (HVMC). Iscador. http://www.hvmc.info/hvmc_iscador.html. Not publication date available. Accessed November 16, 2022.
  11. Büssing A. Mistletoe: The Genus Viscum. Harwood Academic Publishing; 2000.
  12. Iscador AG. Integrative cancer treatment with mistletoe therapy. Accessed November 18, 2022. https://iscador.com/en.
  13. Mistletoe-therapy.org. Iscador®. Publication date unavailable. Last updated July 16, 2021. Accessed November 16, 2022. https://www.mistletoe-therapy.org/information-for-patients/preparations/iscadorr.
  14. Mistletoe-therapy.org. The correct storage of mistletoe preparations. Publication date unavailable. Last updated December 18, 2022. Accessed November 16, 2022. https://www.mistletoe-therapy.org/information-for-patients/use/storage.


Did You Find This Helpful? Share It with Your Pack!

Use the buttons to share what you learned on social media, download a PDF, print this out, or email it to your veterinarian.